1983
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
Greene M, Young R, Merrill J, DeVita V. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Research 1983, 43: 1891-8. PMID: 6572558.Peer-Reviewed Original ResearchConceptsRisk of acute nonlymphocytic leukemiaNon-Hodgkin's lymphomaAcute nonlymphocytic leukemiaCases of acute nonlymphocytic leukemiaNonlymphocytic leukemiaTherapy of non-Hodgkin's lymphomaNon-Hodgkin lymphoma cohortNon-Hodgkin's lymphoma patientsSingle-modality therapyModel of leukemogenesisCase-control studyCumulative radiation dosePatients per yearOptimum patient managementHemibody radiationLeukemogenic therapyNational Cancer InstituteChemotherapy durationHistological subtypesChemotherapy doseTreatment regimensBone marrowTotal bodyPatient managementTherapy
1982
Histologic Progression in Non-Hodgkin’s Lymphoma
Hubbard S, Chabner B, DeVita V, Simon R, Berard C, Jones R, Garvin A, Canellos G, Osborne C, Young R. Histologic Progression in Non-Hodgkin’s Lymphoma. Blood 1982, 59: 258-264. DOI: 10.1182/blood.v59.2.258.258.Peer-Reviewed Original ResearchNodular lymphomaHistological progressionLymphoma patientsHistiocytic cell typesProlonged disease-free survivalNon-Hodgkin's lymphoma patientsAssociated with prolonged survivalCell typesIntensive combination chemotherapyNon-Hodgkin's lymphomaDisease-free survivalResponse to chemotherapyNon-HodgkinCombination chemotherapyDiffuse histologyIntensive chemotherapyClinical courseBiopsy specimensProlonged survivalWorsened prognosisLymphomaNodular patternBiopsyClinical trialsDrug treatment